Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: Association with hospital antimicrobial usage

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Su, Chiu Hsia ^a,b   Wang, Jann Tay ^c   Hsiung, Chao A ^d   Chien, Li Jung ^a   Chi, Cheng Liang ^d   Yu, Hui Tzu ^d   Chang, Feng Yee ^a   Chang, Shan Chwen ^c  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOPERAZONE; CEFPIROME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER INFECTION; ARTICLE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII INFECTION; DATA BASE; DEMOGRAPHY; DRUG USE; EMERGENCY CARE; EPIDEMIOLOGICAL DATA; HOSPITAL; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; TAIWAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CROSS INFECTION; DATABASES, FACTUAL; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INCIDENCE; PREVALENCE; TAIWAN;

ACINETOBACTER BAUMANNII;

EID: 84861324067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037788     Document Type: Article

References (36)

1. Munoz-Price LS, Weinstein RA, (2008) Acinetobacter infection. N Engl J Med 358: 1271-1281.
2. Villegas MV, Hartstein AI, (2003) Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 24: 284-295.
3. Cisneros JM, Rodriguez-Bano J, (2002) Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 8: 687-693.
4. Unal S, Garcia-Rodriguez JA, (2005) Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004. Diagn Microbiol Infect Dis 53: 265-271.
5. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, et al. (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51: 3471-3484.
6. Tseng YC, Wang JT, Wu FL, Chen YC, Chie WC, et al. (2007) Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 59: 181-190.
7. Healthcare Infection Control Practices Advisory Committee (HICPAC) (2006) Management of Multidrug-Resistant Organisms in Healthcare Settings, Available: http://www.cdc.gov/ncidod/dhqp/pdf/ar/MDROGuideline2006.pdf.
8. Tsai HT, Wang JT, Chen CJ, Chang SC, (2008) Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units. Diagn Microbiol Infect Dis 62: 298-305.
9. Paterson DL, (2006) The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43 (Suppl 2): S43-48.
10. Lipsitch M, Samore MH, (2002) Antimicrobial use and antimicrobial resistance: a population perspective. [Erratum appears in Emerg Infect Dis 2002 May;8(5):540]. Emerg Infect Dis 8: 347-354.
11. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, et al. (2000) Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31: 101-106.
12. Williams VR, Callery S, Vearncombe M, Simor AE, Williams VR, et al. (2009) The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control 37: 106-110.
13. Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, et al. (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38: 4086-4095.
14. Centers for Disease Control (Taiwan) (2004) Statistics of communicable diseases and surveillance report in Taiwan 2003 (in English). Available: http://www.cdc.gov.tw/public/data/81910502871.pdf.
15. Centers for Disease Control (Taiwan) (2009) Statistics of communicable diseases and surveillance report in Taiwan 2008 (in English). Available: http://www.cdc.gov.tw/public/data/03101433371.pdf.
16. Lee TM, Su CH, Su MJ, Chou WH, Wang LS et al, (2010) Taiwan Nosocomial Infection Surveillance Annual Report, 2008. Infect Control J; 20 107-14 [in Chinese].
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM, (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140.
18. Schreckenberger PC, Daneshvar MI, Weyant RS, (2003) Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative tram-negative rods. In: Murray PR, Baron EJ, Jorgensen JH, editors. Manual of Clinical Microbiology Washington, D.C. ASM press pp. 749-779.
19. Clinical and Laboratory Standards Institute (2008) Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA.
20. Bureau of National Health Insurance (2009) Introduction to the national health insurance in Taiwan (in English) Available: http://www.nhi.gov.tw/webdata/AttachFiles/Attach_13787_1_NationalHealthInsuranceinTaiwan2009.pdf.
21. World Health Organization (WHO) (2007) Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification system: guidelines for ATC classification and defined daily dose assignment-2008.
22. Peleg AY, Seifert H, Paterson DL, (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
23. Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME, (2008) Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 62: 45-55.
24. del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, et al. (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11: 540-546.
25. Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, et al. (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study. Intensive Care Med 32: 1384-1391.
26. Baran G, Erbay A, Bodur H, Onguru P, Akinci E, et al. (2008) Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 12: 16-21.
27. Lee S-O, Kim NJ, Choi S-H, Hyong Kim T, Chung J-W, et al. (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 48: 224-228.
28. Kim Y-A, Choi JY, Kim CK, Kim CO, Kim MS, et al. (2008) Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter. Scand J Infect Dis 40: 234-240.
29. Akinci E, Colpan A, Bodur H, Balaban N, Erbay A, (2005) Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections. J Hosp Infect 59: 317-323.
30. Smolyakov R, Borer A, Riesenberg K, Schlaeffer F, Alkan M, et al. (2003) Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54: 32-38.
31. Kuo H-Y, Yang C-M, Lin M-F, Cheng W-L, Tien N, et al. (2010) Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan. Diagn Microbiol Infect Dis 66: 195-199.
32. Chen C-M, Liu P-Y, Ke S-C, Wu H-J, Wu L-T, (2009) Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan. Diagn Microbiol Infect Dis 63: 394-397.
33. Lu P-L, Doumith M, Livermore DM, Chen T-P, Woodford N, (2009) Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 63: 641-647.
34. Chen T-L, Lee Y-T, Kuo S-C, Hsueh P-R, Chang F-Y, et al. (2010) Emergence and distribution of plasmids bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother 54: 4575-4581.
35. Romanelli R-M, Jesus L-d, Clemente W-T, Lima S-S, Rezende E-M, et al. (2009) Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control. Brazilian Journal of Infectious Diseases 13: 341-347.
36. Lee Y-T, Fung C-P, Wang F-D, Chen C-P, Chen T-L, et al. (2012) Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit. J Microbiol Immunol Infect 45: 43-51.